82 related articles for article (PubMed ID: 17109668)
1. Benign prostatic hyperplasia. Part 2--management.
Wilt TJ; N'Dow J
BMJ; 2008 Jan; 336(7637):206-10. PubMed ID: 18219042
[No Abstract] [Full Text] [Related]
2. [Referral criteria for benign prostatic hyperplasia in primary care: the 2011 update. Comité Científico de Criterios de Derivación en Hiperplasia Benigna de Próstata].
Cózar JM; Castiñeiras J;
Actas Urol Esp; 2012 Mar; 36(3):203-4. PubMed ID: 22277292
[No Abstract] [Full Text] [Related]
3. Primary care physician versus urologist: how does their medical management of LUTS associated with BPH differ?
Miner MM
Curr Urol Rep; 2009 Jul; 10(4):254-60. PubMed ID: 19570485
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of benign prostatic hyperplasia in primary care.
Tanguay S; Awde M; Brock G; Casey R; Kozak J; Lee J; Nickel JC; Saad F
Can Urol Assoc J; 2009 Jun; 3(3 Suppl 2):S92-S100. PubMed ID: 19543429
[TBL] [Abstract][Full Text] [Related]
5. A current review of medical therapy for benign prostatic hyperplasia.
Brown GA; Sussman DO
J Am Osteopath Assoc; 2004 Feb; 104(2 Suppl 2):S11-6. PubMed ID: 15038398
[TBL] [Abstract][Full Text] [Related]
6. Management of benign prostatic hyperplasia by family physicians.
Toguri A; Barkin J
Can J Urol; 2010 Feb; 17 Suppl 1():26-34. PubMed ID: 20170598
[TBL] [Abstract][Full Text] [Related]
7. Management of benign prostatic hyperplasia by the primary care physician in the 21st century: the new paradigm.
Barkin J
Can J Urol; 2008 Aug; 15 Suppl 1():21-30; discussion 30. PubMed ID: 18700062
[TBL] [Abstract][Full Text] [Related]
8. Managing enlarged prostate in primary care.
Naslund MJ; Costa FJ; Miner MM
Int J Clin Pract; 2006 Dec; 60(12):1609-15. PubMed ID: 17109668
[TBL] [Abstract][Full Text] [Related]
9. 5alpha-reductase inhibition for men with enlarged prostate.
Issa MM; Kraft KH
J Am Acad Nurse Pract; 2007 Aug; 19(8):398-407. PubMed ID: 17655569
[TBL] [Abstract][Full Text] [Related]
10. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.
Naslund MJ; Miner M
Clin Ther; 2007 Jan; 29(1):17-25. PubMed ID: 17379044
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
